Pharmacy Articles

Pharmacy

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Dignass AU et al. - Patients with ulcerative colitis given prolonged-release oral mesalamine 2 g once daily had better remission rates, acceptability, and self-reported adherence to therapy compared with patients given oral mesalamine 1 g twice daily.

Related Articles

Medical Management of Ulcerative Colitis
Digestive Diseases, 11/09/09    Relevance Score: 70%

Oxidized Form Of A Common Vitamin May Bring Relief For Ulcerative Colitis
ScienceDaily, 10/02/09    Relevance Score: 69%

Colectomy Rate Comparison After Treatment of Ulcerative Colitis With Placebo or Infliximab
Gastroenterology, 10/06/09    Relevance Score: 68%

Leukocyte apheresis in the management of ulcerative colitis
Saudi Journal of Gastroenterology, 10/05/09    Relevance Score: 68%

Ulcerative Colitis Treatment Reduces Need For Surgery By Almost Half, Study Suggests
ScienceDaily, 10/02/09    Relevance Score: 68%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address